Here are five observations:
1. The market will likely hit $34.7 billion by 2024, up from $16.6 billion in 2016.
2. The rising number of sports injuries and growing adoption of arthroscopic surgeries are spurring market growth.
3. Demand for bone graft substitutes, surgical devices and arthroscopy devices is growing in the market.
4. In 2016, Arthrex accounted for the greatest market share, with Smith & Nephew, DePuy Synthes, Stryker and CONMED following close behind.
5. Johnson & Johnson, Bird & Cronin, Zimmer Biomet, Anika Therapeutics, Ossur, Breg, Mueller Sports Medicine, DJO Global and Medtronic are also key market players.
More articles on sports medicine:
2 concerns keeping Dr. Rick White up at night & what’s exciting in sports medicine
Drs. Luga Podesta, William McCafferty & more: 5 sports medicine physicians on the move
Dr. Allen Sills defends Colts decision allowing quarterback Jacoby Brissett to play after late concussion diagnosis
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
